Raymond G. Morris

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service

Raymond G. Morris, Andrew Black, A. Harris et al. · British Journal of Clinical Pharmacology · 1998 · 142 citations · Full text

Therapeutic Drug Monitoring of Everolimus

Maria Shipkova, Dennis A. Hesselink, David W. Holt et al. · Therapeutic Drug Monitoring · 2016 · 131 citations

Pharmaceutical Science, Immunology, Pharmacotherapy +16

ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE

Ian S Westley, Leonie R. Brogan, Raymond G. Morris et al. · Drug Metabolism and Disposition · 2005 · 108 citations

Comparison of Trough, 2-Hour, and Limited AUC Blood Sampling for Monitoring Cyclosporin (Neoral®) at Day 7 Post–Renal Transplantation and Incidence of Rejection in the First Month

Raymond G. Morris, Graeme R. Russ, Matthew Cervelli et al. · Therapeutic Drug Monitoring · 2002 · 86 citations

Transplant Rejection, C0 Sample, Urology +15

International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring

David W. Holt, Victor W. Armstrong, Andrea Griesmacher et al. · Therapeutic Drug Monitoring · 2002 · 85 citations

Immunology, Pharmacotherapy, International Federation +19